Article Information
History
- March 1, 2023.
Article Versions
- You are currently viewing Version 1 of this article (March 1, 2023 - 16:54).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Nick Bohmann1,2,
- Tomasz Wilmanski1,
- Lisa Levy3,
- Johanna W. Lampe3,
- Thomas Gurry4,5,
- Noa Rappaport1,
- Christian Diener1,* and
- Sean M. Gibbons1,2,6,7,*
- 1Institute for Systems Biology, Seattle, WA 98109, USA
- 2Molecular Engineering Graduate Program, University of Washington, Seattle, WA 98195, USA
- 3Fred Hutchinson Cancer Center, Seattle, WA 98109, USA
- 4Pharmaceutical Biochemistry Group, School of Pharmaceutical Sciences, University of Geneva, Switzerland
- 5Myota GmbH, Berlin, Germany
- 6Departments of Bioengineering and Genome Sciences, University of Washington, Seattle, WA 98195, USA
- 7eScience Institute, University of Washington, Seattle, WA 98195, USA
- ↵*correspondence can be addressed to cdiener{at}isbscience.org and sgibbons{at}isbscience.org